Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Heat shock element (HSE) is a highly conserved cis-regulatory DNA sequence located within the promoter regions of genes involved in the cellular stress response, most notably those encoding heat shock proteins (HSPs) (Vihervaara & Sistonen, 2014). It is characterized by a series of inverted pentameric repeats with the consensus sequence 5'-nGAAn-3', which serves as the high-affinity binding site for Heat Shock Factors, primarily HSF1 in humans (Amini et al., 2022). Upon activation by stressors such as heat, heavy metals, or proteotoxic agents, HSF1 trimers bind to the HSE to drive the rapid transcription of molecular chaperones that facilitate protein refolding and prevent aggregation (Neudegger et al., 2016). While the HSE itself is a genomic feature rather than a protein, it represents the functional nexus of the heat shock response pathway, which is a major area of interest in oncology and neurology. In cancer, the HSF1-HSE interaction is often constitutively active, allowing malignant cells to survive proteotoxic stress and avoid apoptosis (Dong et al., 2019). Conversely, in neurodegenerative diseases, enhancing the activity at the HSE is explored as a method to clear misfolded protein aggregates. Current pharmacological efforts do not target the DNA sequence directly but instead focus on small-molecule inhibitors or activators of HSF1 that modulate its ability to occupy the HSE (Amini et al., 2022).
Inhibition of Heat Shock Factor 1 (HSF1) trimerization or DNA-binding activity, preventing the recruitment of the transcription factor to the Heat shock element (HSE) and subsequent expression of heat shock proteins.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat shock element (HSE).